Systemic Delivery of MicroRNA-101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets

Targeted therapy based on adjustment of microRNA (miRNA)s activity takes great promise due to the ability of these small RNAs to modulate cellular behavior. However, the efficacy of miR-101 replacement therapy to hepatocellular carcinoma (HCC) remains unclear. In the current study, we first observed...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:PLoS Genet
Asıl Yazarlar: Zheng, Fang, Liao, Yi-Ji, Cai, Mu-Yan, Liu, Tian-Hao, Chen, Shu-Peng, Wu, Pei-Hong, Wu, Long, Bian, Xiu-Wu, Guan, Xin-Yuan, Zeng, Yi-Xin, Yuan, Yun-Fei, Kung, Hsiang-Fu, Xie, Dan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Public Library of Science 2015
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4334495/
https://ncbi.nlm.nih.gov/pubmed/25693145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pgen.1004873
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller